632 related articles for article (PubMed ID: 11795432)
1. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
2. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.
Dragnev KH; Pitha-Rowe I; Ma Y; Petty WJ; Sekula D; Murphy B; Rendi M; Suh N; Desai NB; Sporn MB; Freemantle SJ; Dmitrovsky E
Clin Cancer Res; 2004 Apr; 10(7):2570-7. PubMed ID: 15073138
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism.
Langenfeld J; Kiyokawa H; Sekula D; Boyle J; Dmitrovsky E
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12070-4. PubMed ID: 9342364
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells.
Boyle JO; Langenfeld J; Lonardo F; Sekula D; Reczek P; Rusch V; Dawson MI; Dmitrovsky E
J Natl Cancer Inst; 1999 Feb; 91(4):373-9. PubMed ID: 10050872
[TBL] [Abstract][Full Text] [Related]
5. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
7. Retinoid targets in cancer therapy and chemoprevention.
Dragnev KH; Petty WJ; Dmitrovsky E
Cancer Biol Ther; 2003; 2(4 Suppl 1):S150-6. PubMed ID: 14508093
[TBL] [Abstract][Full Text] [Related]
8. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.
Spinella MJ; Freemantle SJ; Sekula D; Chang JH; Christie AJ; Dmitrovsky E
J Biol Chem; 1999 Jul; 274(31):22013-8. PubMed ID: 10419526
[TBL] [Abstract][Full Text] [Related]
10. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
11. Uncovering novel targets for cancer chemoprevention.
Dragnev KH; Feng Q; Ma Y; Shah SJ; Black C; Memoli V; Nugent W; Rigas JR; Kitareewan S; Freemantle S; Dmitrovsky E
Recent Results Cancer Res; 2007; 174():235-43. PubMed ID: 17302201
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells.
Seewaldt VL; Kim JH; Caldwell LE; Johnson BS; Swisshelm K; Collins SJ
Cell Growth Differ; 1997 Jun; 8(6):631-41. PubMed ID: 9185997
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
Roy B; Taneja R; Chambon P
Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
[TBL] [Abstract][Full Text] [Related]
15. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
16. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation.
Langenfeld J; Lonardo F; Kiyokawa H; Passalaris T; Ahn MJ; Rusch V; Dmitrovsky E
Oncogene; 1996 Nov; 13(9):1983-90. PubMed ID: 8934545
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
[TBL] [Abstract][Full Text] [Related]
18. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
[TBL] [Abstract][Full Text] [Related]
20. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
